Skip to main content
SpringerLink
Log in

Self-Management Techniques in IBD

  • Chapter
  • First Online:
Book cover Telemanagement of Inflammatory Bowel Disease

Abstract

Irrespective of the strength of a patient’s inflammatory bowel disease (IBD) care team, an individual will still likely spend less than 3 h per year obtaining care or in communication with their provider(s) and the rest of the time “self-managing.” In this chapter, we (1) define self-management and discuss the unique features of IBD which make self-management particularly challenging, (2) describe the role of self-management support on health outcomes in IBD, and (3) discuss the importance of social-cognitive theory in the development and implementation of self-management support for IBD, including the types of techniques, constructs, and sample programs which fit within this model.

Self-management support programs are typically problem based, meaning they identify and promote the development of skills that solve a critical aspect of disease management. Tools or programs which support skills such as improving medication adherence, increasing disease knowledge, implementing decision-support tools, or optimizing communication between patients and providers are all problem-focused ways in which IBD self-management can be readily supported. While traditional self-management programs targeting a single problem can be quite effective, self-management support initiatives may be better suited to approaches which integrate the complex interactions between the thoughts, feelings, and behaviors that accompany IBD (patient modifiers) and the physical and environmental demands the disease presents (disease modifiers). Social-cognitive theory lends itself well to this problem.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lorig K. Self-management education: more than a nice extra. Med Care. 2003;41(6):699–701.

    PubMed  Google Scholar 

  2. Lorig KR, et al. A national dissemination of an evidence-based self-management program: a process evaluation study. Patient Educ Couns. 2005;59(1):69–79.

    Article  PubMed  Google Scholar 

  3. Burgmann T, Rawsthorne P, Bernstein CN. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use? Am J Gastroenterol. 2004;99(5):889–93.

    Article  PubMed  Google Scholar 

  4. Loftus CG, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007;13(3):254–61.

    Article  PubMed  Google Scholar 

  5. Bernstein CN. Treatment of the extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep. 2002;4(6):513–6.

    Article  PubMed  Google Scholar 

  6. Averill RF, et al. Achieving cost control, care coordination, and quality improvement through incremental payment system reform. J Ambul Care Manage. 2010;33(1):2–23.

    Article  PubMed  Google Scholar 

  7. Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26(1):1–7.

    Article  PubMed  Google Scholar 

  8. Kane S, Cohen RD, Aikens JE, Hanauer SB. Predictors of non-compliance with mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929–32.

    Article  CAS  PubMed  Google Scholar 

  9. Higgins PD, et al. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther. 2009;29(3):247–57.

    Article  CAS  PubMed  Google Scholar 

  10. Kane S. Medication adherence and the physician–patient relationship. Am J Gastroenterol. 2002;97(7):1853.

    Article  PubMed  Google Scholar 

  11. Kane S. Is non-adherence to blame? Inflamm Bowel Dis. 2005;11(7):705.

    Article  PubMed  Google Scholar 

  12. Kane S, Dixon L. Adherence rates with infliximab therapy in Crohn’s disease. Aliment Pharmacol Ther. 2006;24(7):1099–103.

    Article  CAS  PubMed  Google Scholar 

  13. Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008;53(4):1020–4.

    Article  PubMed  Google Scholar 

  14. Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2006;23(5):577–85.

    Article  CAS  PubMed  Google Scholar 

  15. Kane SV. Strategies to improve adherence and outcomes in patients with ulcerative colitis. Drugs. 2008;68(18):2601–9.

    Article  PubMed  Google Scholar 

  16. Kane SV, Chao J, Mulani PM. Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patients. Adv Ther. 2009;26(10):936–46.

    Article  CAS  PubMed  Google Scholar 

  17. Ediger JP, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102(7):1417–26.

    Article  PubMed  Google Scholar 

  18. Shale M, Riley SA. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Alimentary Pharmacol Ther. 2003;18(2):191–203.

    Article  CAS  Google Scholar 

  19. Sewitch M, Abrahamowicz M., Barkun A., Bitton A., Wild GE, Cohen A., Dobkin PL. Patient non-adherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98(7):1535–44.

    Article  PubMed  Google Scholar 

  20. Lakatos PL, et al. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. J Crohns Colitis. 2010;4(3):283–90.

    Article  PubMed  Google Scholar 

  21. Moser G., Maeir-Dobersberger T, Vogelsang H, Lochs H, Inflammatory bowel disease: patients beliefs about the etiology of their disease—a controlled study. Psychosom Med. 1993;55:131.

    Google Scholar 

  22. Bitton A, Sewitch M, Peppercorn MA, deB Edwardes MD, Shah S, Ransil B, Locke SE. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol. 2003;98(10):2203–8.

    Article  PubMed  Google Scholar 

  23. Bernstein CN, Walker JR, Graff LA. On studying the connection between stress and IBD. Am J Gastroenterol. 2006;101(4):782–5.

    Article  PubMed  Google Scholar 

  24. Keefer L, Keshavarzian A, Mutlu E. Reconsidering the methodology of “stress” research in inflammatory bowel disease. J Crohns Colitis. 2008;2(3):193–201.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Mawdsley J, Macey MG, Feakins RM, Langmead L, Rampton DS. The effect of acute psychological stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology. 2006;131:410–19.

    Article  CAS  PubMed  Google Scholar 

  26. Mawdsley J, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54:1481–91.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Maunder R. Evidence that stress contributes to inflammatory bowel disease: evaluation, synthesis and future directions. Inflamm Bowel Dis. 2005;11(6):600–8.

    Google Scholar 

  28. Levenstein S, Prantera C, Varvo V, Scibano ML, Berto E, Andreoli A, Luzi C. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol. 1994;89(8):1219–25.

    CAS  PubMed  Google Scholar 

  29. Graff LA, et al. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls. Am J Gastroenterol. 2009;104(12):2959–69.

    Article  PubMed  Google Scholar 

  30. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009;15(7):1105–18.

    Google Scholar 

  31. Larsson K., Loof L, Ronnblom A, Nordin K. Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. J Psychosom Res. 2008;64:139–48.

    Article  PubMed  Google Scholar 

  32. Jones, M., Wessinger S, Crowell MD. Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4(4):474–81.

    Article  PubMed  Google Scholar 

  33. Baars JE, et al. Patients’ preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment study. Digestion. 2010;81(2):113–9.

    Article  PubMed  Google Scholar 

  34. Dupuis M, et al. Assessing the educational needs of Canadian gastroenterologists and gastroenterology nurses: challenges to optimal care in Crohn’s Disease. Can J Gastroenterol. 2009;23(12):805–10.

    PubMed Central  PubMed  Google Scholar 

  35. Moser G, et al. Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res. 1996;40(5):503–9.

    Article  CAS  PubMed  Google Scholar 

  36. Shoor S, Lorig KR. Self-care and the doctor–patient relationship. Med Care. 2002;40(4 Suppl):II40–44.

    Google Scholar 

  37. Andrews JM, et al. Un-promoted issues in inflammatory bowel disease: opportunities to optimize care. Intern Med J. 2010;40(3):173–82.

    Article  CAS  PubMed  Google Scholar 

  38. Barrett SM, Standen PJ, Lee AS, Hawkey CJ, Logan RF. Personality, smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1996;8:651–5.

    CAS  PubMed  Google Scholar 

  39. de Rooy E, Toner BB, Maunder RG, Greenberg GR, Baron D, Steinhart H, McLeod R, Cohen Z. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol. 2001;96(6):1816–21.

    Article  PubMed  Google Scholar 

  40. Lewis M. Attributions and inflammatory bowel disease: patients’ perceptions of their ilness causes and effects of these perceptions on relationships. Alberta Association of Registered Nurses (AARN) News Lett. 1998;44(5):16-17.

    Google Scholar 

  41. Kiebles JL, Doerfler B, Keefer L. Preliminary evidence supporting a framework of psychological adjustment to inflammatory bowel disease. Inflamm Bowel Dis. 2010;16(10):1685–95.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Pihl-Lesnovska K, et al. Patients’ perspective of factors influencing quality of life while living with Crohn disease. Gastroenterol Nurs. 2010;33(1):37–44; quiz 45–6.

    Google Scholar 

  43. Malik BA, et al. Health-related quality of life in pediatric ulcerative colitis patients on conventional medical treatment compared to those after restorative proctocolectomy. Int J Colorectal Dis. 2013;28(3):325–33.

    Article  PubMed  Google Scholar 

  44. van der Eijk I, et al. The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis. 2004;10(4):392–8.

    Article  PubMed  Google Scholar 

  45. Trivedi I, Keefer L. Management of the emerging adult with IBD: optimizing transition and addressing challenges from the adult gastroenterologist perspective. Gastroenterol Res Pract. 2015. in press.

    Google Scholar 

  46. Moen A, Brennan P. Health@Home: the work of health information management in the household (HIMH): implications for consumer health informatics (CHI) innovations. J Am Med Inform Assoc. 2005;12(6):648–56.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Kane S. Information needs and preferences in IBD (IBD self-management: the AGA guide to Crohn’s disease and ulcerative colitis). Inflamm Bowel Dis. 2011;17(8):E102.

    Article  PubMed  Google Scholar 

  48. Ory MG, et al. National study of chronic disease self-management: age comparison of outcome findings. Health Educ Behav. 2014;41(1 Suppl):34–42 S.

    Google Scholar 

  49. Holman H, Lorig K. Patient self-management: a key to effectiveness and efficiency in care of chronic disease. Public Health Rep. 2004;119(3):239–43.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Ahn S, et al. The impact of chronic disease self-management programs: healthcare savings through a community-based intervention. BMC Public Health. 2013;13:1141.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Institute of Medicine (US) Committee on Quality of Health Care in America Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press (US); 2001.

    Google Scholar 

  52. Barlow C, et al. A critical review of self-management and educational interventions in inflammatory bowel disease. Gastroenterol Nurs. 2010;33(1):11–8.

    Article  PubMed  Google Scholar 

  53. McCombie AM, Mulder RT, Gearry RB. Psychotherapy for inflammatory bowel disease: a review and update. J Crohns Colitis. 2013;7(12):935–49.

    Article  PubMed  Google Scholar 

  54. Knowles SR, Monshat K, Castle DJ. The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review. Inflamm Bowel Dis. 2013;19(12):2704–15.

    Article  PubMed  Google Scholar 

  55. Lim JW, et al. Understanding the cultural health belief model influencing health behaviors and health-related quality of life between Latina and Asian-American breast cancer survivors. Support Care Cancer. 2009;17(9):1137–47.

    Article  PubMed  Google Scholar 

  56. Scarinci IC, Bandura L, Hidalgo B, Cherrington A. Development of a theory-based (PEN-3 and Health Belief Model), culturally relevant intervention on cervical cancer prevention among Latina immigrants using intervention mapping. Health Promot Pract. 2012;13(1):29-40

    Google Scholar 

  57. Wang JH, et al. The influence of culture and cancer worry on colon cancer screening among older Chinese-American women. Ethn Dis. 2006;16(2):404–11.

    PubMed Central  PubMed  Google Scholar 

  58. van Weert JC, van Noort G, Bol N, van Dijk L, Tates K, Jansen J. Tailored information for cancer patients on the Internet: effects of visual cues and language complexity on information recall and satisfaction. Patient Educ Couns. 2011;84(3):368-78.

    Google Scholar 

  59. Ackerson LK, Viswanath K. The social context of interpersonal communication and health. J Health Commun. 2009;14(Suppl 1):5–17.

    Google Scholar 

  60. Viswanath K, Ackerson LK. Race, ethnicity, language, social class, and health communication inequalities: a nationally-representative cross-sectional study. PLoS One. 2011;6(1):e14550.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  61. Clayman ML, et al. Providing health messages to Hispanics/Latinos: understanding the importance of language, trust in health information sources, and media use. J Health Commun. 2010;15(Suppl 3):252–63.

    Google Scholar 

  62. Arora NK, et al. Frustrated and confused: the American public rates its cancer-related information-seeking experiences. J Gen Intern Med. 2008;23(3):223–8.

    Article  PubMed Central  PubMed  Google Scholar 

  63. Jimison H, Gorman P, Woods S, et al. Barriers and drivers of health information technology use for the elderly, chronically ill, and underserved. Evidence Report/Technology Assessment Association for Healthcare Research and Quality (AHRQ), Editor. 2008, National Institutes of Health: Rockville, MD.

    Google Scholar 

  64. Cima RR, et al. Internet use by patients in an inflammatory bowel disease specialty clinic. Inflamm Bowel Dis. 2007;13(10):1266–70.

    Article  PubMed  Google Scholar 

  65. O’Dea B, Campbell A. Healthy connections: online social networks and their potential for peer support. Stud Health Technol Inform. 2011;168:133–40.

    PubMed  Google Scholar 

  66. Eysenbach G, et al. Health related virtual communities and electronic support groups: systematic review of the effects of online peer to peer interactions. BMJ. 2004;328(7449):1166.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Seabrook HJ, et al. Medical applications: a database and characterization of apps in Apple iOS and Android platforms. BMC Res Notes. 2014;7:573.

    Article  PubMed Central  PubMed  Google Scholar 

  68. Siegel CA. Lost in translation: helping patients understand the risks of inflammatory bowel disease therapy. Inflamm Bowel Dis. 2010;16(12):2168–72.

    Article  PubMed Central  PubMed  Google Scholar 

  69. National Institute of Mental Health Multisite HIV Prevention Trial Group. Social-cognitive theory mediators of behavior change in the National Institute of Mental Health Multisite HIV Prevention Trial. Health Psychol. 2001;20(5):369–76.

    Google Scholar 

  70. Berrill JW, et al. Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. J Crohns Colitis. 2014;8(9):945–55.

    Article  PubMed  Google Scholar 

  71. Schoultz M, et al. The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation. Trials. 2013;14:431.

    Article  PubMed Central  PubMed  Google Scholar 

  72. Gaylord SA, et al. Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial. BMC Complement Altern Med. 2009;9:24.

    Article  PubMed Central  PubMed  Google Scholar 

  73. Mawdsley JE, et al. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol. 2008;103(6):1460–9.

    Article  PubMed  Google Scholar 

  74. Keefer L, et al. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther. 2013;38(7):761–71.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  75. Keefer L, et al. The potential role of a self-management intervention for ulcerative colitis: a brief report from the ulcerative colitis hypnotherapy trial. Biol Res Nurs. 2012;14(1):71–7.

    Article  PubMed Central  PubMed  Google Scholar 

  76. Bandura A. Social cognitive theory: an agentic perspective. Annu Rev Psychol. 2001;52:1–26.

    Article  CAS  PubMed  Google Scholar 

  77. Keefer L, Doerfler B, Artz C. Optimizing management of Crohn’s disease within a project management framework: results of a pilot study. Inflamm Bowel Dis. 2012;18(2):254–60.

    Article  PubMed Central  PubMed  Google Scholar 

  78. Vogelaar L, et al. Solution focused therapy: a promising new tool in the management of fatigue in Crohn’s disease patients psychological interventions for the management of fatigue in Crohn’s disease. J Crohns Colitis. 2011;5(6):585–91.

    Article  PubMed  Google Scholar 

  79. Grzes M, Kudenko D. Online learning of shaping rewards in reinforcement learning. Neural Netw. 2010;23(4):541–50.

    Article  PubMed  Google Scholar 

  80. Zheng M, Lu L, Zhao M. Spreading in online social networks: the role of social reinforcement. Phys Rev E Stat Nonlin Soft Matter Phys. 2013;88(1):012818.

    Article  PubMed  Google Scholar 

  81. Si J, Wang YT. Online learning control by association and reinforcement. IEEE Trans Neural Netw. 2001;12(2):264–76.

    Article  CAS  PubMed  Google Scholar 

  82. Hoffman AJ, et al. Testing a theoretical model of perceived self-efficacy for cancer-related fatigue self-management and optimal physical functional status. Nurs Res. 2009;58(1):32–41.

    Article  PubMed Central  PubMed  Google Scholar 

  83. Airlie J, Baker GA, Smith SJ, Young CA. Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale. Clinical Rehabilitation. 2001;15(3):259–65.

    Google Scholar 

  84. Sarkar U, Ali S, Whooley MA. Self-efficacy as a marker of cardiac function and predictor of heart failure hospitalization and mortality in patients with stable coronary heart disease: findings from the heart and soul study. Health Psychology. 2009;28(2):166–73.

    Article  PubMed Central  PubMed  Google Scholar 

  85. Bernal H, Woolley S, Schenaul J, Dickinson J. Correlates of self-efficacy in diabetes self-care among Hispanic adults with diabetes. Diabetes Educ. 2000;26:673–80.

    Article  CAS  PubMed  Google Scholar 

  86. McAuley E, Lox C, Duncan TE. Long-term maintenance of exercise, self-efficacy and physiological change in older adults. J Gerontol. 1993;48:218–24.

    Article  Google Scholar 

  87. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84:191–215.

    Article  CAS  PubMed  Google Scholar 

  88. Keefer L, Kiebles JL, Taft TH. The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure. Inflamm Bowel Dis. 2011;17(2):614–20.

    Article  PubMed Central  PubMed  Google Scholar 

  89. Kennedy AP, et al. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut. 2004;53(11):1639–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  90. Robinson A, et al. Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial. Lancet. 2001;358(9286):976–81.

    Article  CAS  PubMed  Google Scholar 

  91. Hommel KA, et al. Self-management in pediatric inflammatory bowel disease: a clinical report of the North American Society for pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2013;57(2):250–7.

    Article  PubMed Central  PubMed  Google Scholar 

  92. Fishman LN, et al. Self-management of older adolescents with inflammatory bowel disease: a pilot study of behavior and knowledge as prelude to transition. Clin Pediatr (Phila). 2010;49(12):1129–33.

    Article  Google Scholar 

  93. Sadowski DC, et al. Canadian Association of Gastroenterology clinical practice guidelines: the use of tumour necrosis factor-alpha antagonist therapy in Crohn’s disease. Can J Gastroenterol. 2009;23(3):185–202.

    PubMed Central  CAS  PubMed  Google Scholar 

  94. Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn’s disease in adults. Am J Gastroenterol. 2009;104(2):465–83; quiz 464, 484.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Laurie Keefer

  2. Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, 55905, Rochester, MN, USA

    Sunanda Kane MD, MSPH

Authors
  1. Laurie Keefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sunanda Kane MD, MSPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunanda Kane MD, MSPH .

Editor information

Editors and Affiliations

  1. Department of Medicine, Division of Gastroenterology and Hepatology, University of Maryland, Baltimore, Baltimore, Maryland, USA

    Raymond K. Cross

  2. Department of Colorectal Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    Andrew R. Watson

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Keefer, L., Kane, S. (2016). Self-Management Techniques in IBD. In: Cross, R., Watson, A. (eds) Telemanagement of Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-22285-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22285-1_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22284-4

  • Online ISBN: 978-3-319-22285-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation